Idiopathic hypereosinophilic syndrome with eosinophilic cellulitis-like cutaneous involvement treated with mepolizumab and dapsone

• Madeleine Lachance, MD,
• Jean Bernard, MD, FRCPC,
• Aubert Lavoie, MD, FRCPC,
• Éric Gagné, MD, FRCPC,
• Pierre-Olivier Grenier, MD, FRCPC

Affiliations

Madeleine Lachance, MD

Department of Dermatology, Centre Hospitalier Universitaire de Québec, Université Laval, Québec, Canada; Correspondence to: Madeleine Lachance, MD, Department of Dermatology, Centre Hospitalier Universitaire de Québec, Université Laval, Hôtel-Dieu de Québec 11, Côte du Palais, G1R 2J6 Québec, Québec, Canada.

Jean Bernard, MD, FRCPC

Department of Dermatology, Centre Hospitalier Universitaire de Québec, Université Laval, Québec, Canada

Aubert Lavoie, MD, FRCPC

Department of Immunology and Allergology, Centre Hospitalier Universitaire de Québec, Université Laval, Québec, Canada

Éric Gagné, MD, FRCPC

Department of Pathology, Centre Hospitalier Universitaire de Québec, Université Laval, Québec, Canada

Pierre-Olivier Grenier, MD, FRCPC

Department of Dermatology, Centre Hospitalier Universitaire de Québec, Université Laval, Québec, Canada